One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Transgender women with prostate cancer are under-represented in national cancer registries
Elie Kaplan-Marans, Tenny R. Zhang, Lee C. Zhao & Jim C. HuÂ
doi : 10.1038/s41585-022-00688-w
Volume 20 Issue 4, April 2023
Detecting lymph node metastases for personalized radiotherapy in patients with prostate cancer
Tim ThomasÂ
Temporary cessation versus continued TKI therapy for RCC
Maria Chiara MasoneÂÂ
The role of GALNT7 as a potential diagnostic marker in prostate cancer
Maria Chiara MasoneÂÂ
Singling out the immune-suppressive TME in prostate cancer
Louise StoneÂÂ
Rucaparib improves PFS in patients with BRCA1/2-altered mCRPC
Louise StoneÂÂ
Does immune cell exhaustion lie at the heart of BCG-unresponsive disease?
Molly A. IngersollÂÂ
Evolving the surgical approach for bladder cancer � robotic versus open radical cystectomy
Sagar R. Patel & Seth P. LernerÂ
Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations
Pawel Rajwa, Fahad Quhal, Benjamin Pradere, Giorgio Gandaglia, Guillaume Ploussard, Michael S. Leapman, John L. Gore, Andrzej Paradysz, Derya Tilki, Axel S. Merseburger, Todd M. Morgan, Alberto Briganti, Ganesh S. Palapattu & Shahrokh F. ShariatÂ
doi : 10.1038/s41585-022-00680-4
Mutations in the BRCA1 and BRCA2 tumour suppressor genes are associated with prostate cancer risk; however, optimal screening protocols for individuals with these mutations have been a subject of debate.
High-dose chemotherapy for relapsed testicular germ cell tumours
Michal Chovanec, Nabil Adra, Mohammad Abu Zaid, Rafat Abonour & Lawrence EinhornÂ
doi : 10.1038/s41585-022-00683-1
Relapsed testicular germ cell tumours (GCTs) might be cured with salvage chemotherapy. Accepted salvage treatment is conventional-dose chemotherapy (CDCT) or high-dose chemotherapy (HDCT). HDCT with peripheral blood stem cell transplant might produce a higher number of durable responses than CDCT.
Relationships between holmium laser enucleation of the prostate and prostate cancer
Matthew S. Lee, Mark A. Assmus, Jenny Guo, Mohammad R. Siddiqui, Ashley E. Ross & Amy E. KrambeckÂ
doi : 10.1038/s41585-022-00678-y
Holmium laser enucleation of the prostate (HoLEP) is a size-independent surgical option for treating benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) with excellent, durable functional outcomes.
Landmarks in the evolution of prostate biopsy
Martin J. Connor, Michael A. Gorin, David Eldred-Evans, Edward J. Bass, Ankit Desai, Tim Dudderidge, Mathias Winkler & Hashim U. AhmedÂ
doi : 10.1038/s41585-022-00684-0
Approaches and techniques used for diagnostic prostate biopsy have undergone considerable evolution over the past few decades: from the original finger-guided techniques to the latest MRI-directed strategies, from aspiration cytology to tissue core sampling, and from transrectal to transperineal approaches.
